Home›Search›Journal of Nephropharmacology

Journal of Nephropharmacology

Society of Diabetic Nephropathy Prevention · Iran · Est. 2017

ISSN2345-4202

SJR Q3✓ Scopus / SJR✓ DOAJ✓ Open Access

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 75% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.196

H-Indexi

SNIPi

0.249

Total Worksi

243

Total Citationsi

603

2yr Mean Citednessi

0.91

Open Impact Factor alternative

Aims & Scope

Subject areas: Nephrology; Pharmacology (medical).

General Information

Country / RegionIran

Primary LanguageEnglish

1st Year Published2017

Annual Volume~ 27 articles / year

StatusActive (last: 2025)

Total Publications243

Publisher OrgNickan Research Institute

Region🌍 Global South

OA Since2016

Visit Journal Website

Submission Info

Peer ReviewDouble-blind

OA LicenseCC BY

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

9/11 · 82%

✅

Do you know the journal / publisher?

Society of Diabetic Nephropathy Prevention

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2345-4202

✅

Indexed in a trusted database?

Scopus, DOAJ, PubMed

✅

Peer review process documented?

Double-blind

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

104

2019

169

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

NephrologyQ3

Pharmacology (medical)Q4

Subject Classification

Scopus Categories

Pharmacology (medical)Nephrology

Research Topics (OpenAlex)

Renal Diseases and GlomerulopathiesDialysis and Renal Disease ManagementAcute Kidney Injury ResearchChronic Kidney Disease and DiabetesParathyroid Disorders and TreatmentsCOVID-19 Clinical Research StudiesHemoglobinopathies and Related DisordersMuscle and Compartmental DisordersDiabetes, Cardiovascular Risks, and LipoproteinsDrug-Induced Hepatotoxicity and Protection

Frequently asked questions about Journal of Nephropharmacology

Is Journal of Nephropharmacology a predatory journal?

PubScope has no integrity flags on record for Journal of Nephropharmacology: it is indexed in Scopus, DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Journal of Nephropharmacology?

Journal of Nephropharmacology is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.196.

Is Journal of Nephropharmacology indexed in Scopus and Web of Science?

Journal of Nephropharmacology is indexed in Scopus, DOAJ.

What is the aims and scope of Journal of Nephropharmacology?